INTRAVENOUS-INFUSION OF THE NMDA ANTAGONIST, KETAMINE, IN CHRONIC POSTTRAUMATIC PAIN WITH ALLODYNIA - A DOUBLE-BLIND COMPARISON TO ALFENTANIL AND PLACEBO
Mb. Max et al., INTRAVENOUS-INFUSION OF THE NMDA ANTAGONIST, KETAMINE, IN CHRONIC POSTTRAUMATIC PAIN WITH ALLODYNIA - A DOUBLE-BLIND COMPARISON TO ALFENTANIL AND PLACEBO, Clinical neuropharmacology, 18(4), 1995, pp. 360-368
NMDA antagonists and opioids relieve experimentally produced hyperalge
sia in animals and humans, presumably by attenuating a heightened cent
ral nervous system response to afferent input, A few small studies in
patients have suggested that intravenous boluses or rapid infusions of
the N-methyl-D-aspartate (NMDA) antagonist ketamine relieve some neur
opathic pains but also produce disturbances of cognition and mood, In
a randomized, double-blind, crossover trial, we treated eight patients
with chronic posttraumatic pain and widespread mechanical allodynia w
ith 2-h intravenous infusions of the NMDA antagonist ketamine (mean do
se, 58 mg), the opioid mu-receptor agonist alfentanil (mean dose, 11 m
g), and placebo. The patients were selected because extensive sensory
testing suggested that altered central processing contributed to their
symptoms. The slow rate of drug infusion was chosen to see if pain re
lief would precede dose-limiting side effects. Means of the peak effec
t scores achieved during the 2-h infusion were for pain relief: ketami
ne, 65%, alfentanil, 46%, and placebo, 22% (p < 0.01 for ketamine and
p = 0.08 for alfentanil, each compared to placebo); and for relief of
allodynia: ketamine, 71%, alfentanil, 57%, and placebo, 21% (p < 0.01
for both ketamine and alfentanil). Appreciable symptomatic relief deve
loped only after the onset of unpleasant drug side effects. After the
infusion was stopped, pain relief disappeared before the side effects
resolved, We conclude that NMDA antagonists may have promise for the t
reatment of neuropathic pain, but strategies are needed to improve the
ir therapeutic ratio, such as intrathecal administration or systemic t
reatment with more selective drugs.